LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

Search

AcelRx Pharmaceuticals Inc

Затворен

0

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

Максимум

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+532.91 upside

AcelRx Pharmaceuticals Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

28.10.2024 г., 23:02 ч. UTC

Топ новини

Australian Consumer-Confidence Recovery Still Intact Amid Building Rate-Cut Hopes

28.10.2024 г., 23:01 ч. UTC

Значими двигатели на пазара

Lithium Americas Shares Rise After News of DOE Loan

28.10.2024 г., 22:40 ч. UTC

Печалби

Correction to Bristol-Myers Squibb 2024 Guidance Headline on July 26

28.10.2024 г., 22:29 ч. UTC

Печалби

Waste Management Posts Revenue Growth on Price Increases

28.10.2024 г., 23:52 ч. UTC

Топ новини

McDonald's Finds an Unlikely Savior to Finally Fix Its McFlurry Machines -- Update

28.10.2024 г., 23:42 ч. UTC

Пазарно говорене

Lithium Spodumene Prices Have Likely Bottomed -- Market Talk

28.10.2024 г., 23:07 ч. UTC

Топ новини

McDonald's Finds an Unlikely Savior to Finally Fix Its McFlurry Machines -- WSJ

28.10.2024 г., 23:00 ч. UTC

Печалби

WuXi AppTec 3Q Rev CNY10.46B, Down 2% on Year >603259.SH

28.10.2024 г., 22:59 ч. UTC

Печалби

WuXi AppTec 3Q Net CNY2.29B , Down 17% on Year >603259.SH

28.10.2024 г., 22:15 ч. UTC

Печалби

Sandfire Resources Net Debt $345 Million at End-Sept

28.10.2024 г., 22:15 ч. UTC

Печалби

Sandfire Resources 1Q Underlying Ebitda $121 Million

28.10.2024 г., 22:15 ч. UTC

Печалби

Sandfire Resources 1Q Unaudited Sales Revenue $282 Million

28.10.2024 г., 22:14 ч. UTC

Печалби

Sandfire Resources 1Q Underlying Operating Cost of $78/Ton of Ore Processed at Matsa Operation

28.10.2024 г., 22:14 ч. UTC

Печалби

Sandfire Resources 1Q Underlying Operating Cost of $40/Ton of Ore Processed at Motheo Operation

28.10.2024 г., 22:13 ч. UTC

Печалби

Sandfire Resources Says Copper Equivalent Output at Matsa Operation Up 4% in 1Q

28.10.2024 г., 22:13 ч. UTC

Печалби

Sandfire Resources Reaffirms FY 2025 Output, Cost, Capex Guidance

28.10.2024 г., 22:12 ч. UTC

Печалби

Sandfire Resources 1Q Silver Output 1.3 Million Oz, Up 9% on Quarter

28.10.2024 г., 22:12 ч. UTC

Печалби

Sandfire Resources 1Q Lead Output 2,081 Tons, Up 9% on Quarter

28.10.2024 г., 22:12 ч. UTC

Печалби

Sandfire Resources 1Q Zinc Output 21,542 Tons, Down 1% on Quarter

28.10.2024 г., 22:11 ч. UTC

Печалби

Sandfire Resources 1Q Copper Output 27,012 Tons, Down 1% on Quarter

28.10.2024 г., 22:11 ч. UTC

Печалби

Sandfire Resources 1Q Copper Equivalent Output 38,000 Tons, Flat on Quarter

28.10.2024 г., 22:07 ч. UTC

Печалби

China Southern Airlines: Strong Travel Demand Supported Results >1055.HK

28.10.2024 г., 22:07 ч. UTC

Печалби

China Southern Airlines 9-Mos Rev CNY134.66B Vs. CNY119.49B >1055.HK

28.10.2024 г., 22:07 ч. UTC

Печалби

China Southern Airlines 9-Mos Net CNY1.97B Vs. Net CNY1.32B >1055.HK

28.10.2024 г., 22:01 ч. UTC

Печалби

CMOC Group: Higher Income From Mining and Processing Segment Supported Results >3993.HK

28.10.2024 г., 22:00 ч. UTC

Печалби

CMOC Group 3Q Rev CNY51.94B, Up 15.5% on Year >3993.HK

28.10.2024 г., 21:59 ч. UTC

Печалби

CMOC Group 3Q Net CNY2.86B , Up 64.1% on Year >3993.HK

28.10.2024 г., 21:38 ч. UTC

Придобивния, сливания и поглъщания

Fomento Economico Mexicano to Sell Plastics Solutions Operations to AMMI for MXN3.17B

28.10.2024 г., 21:23 ч. UTC

Печалби

Waste Management Raises 2024 Revenue View to Up 6% >WM

28.10.2024 г., 21:21 ч. UTC

Печалби

Waste Management 3Q Adj EPS $1.96 >WM

Сравнение с други в отрасъла

Ценова промяна

AcelRx Pharmaceuticals Inc Прогноза

Ценова цел

By TipRanks

532.91% нагоре

12-месечна прогноза

Среден 5 USD  532.91%

Висок 5 USD

Нисък 5 USD

Според 1 анализатори от Wall Street, предложили 12-месечна ценова цел за AcelRx Pharmaceuticals Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

1 ratings

1

Купи

0

Задържане

0

Продай

Финанси

$